Search

Masoud H. Noori

Examiner (ID: 3784, Phone: (571)272-2185 , Office: P/2855 )

Most Active Art Unit
2855
Art Unit(s)
2855, 2214, 2856, 2616
Total Applications
3955
Issued Applications
3448
Pending Applications
170
Abandoned Applications
350

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17755726 [patent_doc_number] => 11396007 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-26 [patent_title] => Catalyst supports--composition and process of manufacture [patent_app_type] => utility [patent_app_number] => 17/405201 [patent_app_country] => US [patent_app_date] => 2021-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9596 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405201 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/405201
Catalyst supports--composition and process of manufacture Aug 17, 2021 Issued
Array ( [id] => 18739480 [patent_doc_number] => 20230348410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => PURIFICATION OF 2,5-FURANDICARBOXYLIC ACID, DIMETHYL ESTER AND OTHER ESTERIFIED PRODUCTS [patent_app_type] => utility [patent_app_number] => 18/041394 [patent_app_country] => US [patent_app_date] => 2021-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9411 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041394 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/041394
PURIFICATION OF 2,5-FURANDICARBOXYLIC ACID, DIMETHYL ESTER AND OTHER ESTERIFIED PRODUCTS Jul 28, 2021 Pending
Array ( [id] => 17356754 [patent_doc_number] => 20220017550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => 3-PYRROLIDINE-INDOLE DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS [patent_app_type] => utility [patent_app_number] => 17/387864 [patent_app_country] => US [patent_app_date] => 2021-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37468 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 562 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17387864 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/387864
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders Jul 27, 2021 Issued
Array ( [id] => 18748317 [patent_doc_number] => 11807613 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-07 [patent_title] => Integrated methods for chemical synthesis [patent_app_type] => utility [patent_app_number] => 17/386627 [patent_app_country] => US [patent_app_date] => 2021-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 24167 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386627 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/386627
Integrated methods for chemical synthesis Jul 27, 2021 Issued
Array ( [id] => 18764018 [patent_doc_number] => 11814404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-14 [patent_title] => Inhibitors of complement factors and uses thereof [patent_app_type] => utility [patent_app_number] => 17/379334 [patent_app_country] => US [patent_app_date] => 2021-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 123439 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 386 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379334 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/379334
Inhibitors of complement factors and uses thereof Jul 18, 2021 Issued
Array ( [id] => 18146194 [patent_doc_number] => 20230020051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => METHOD AND INTEGRATED PROCESS FOR THE CARBOXYLATION OF FURAN DERIVED CARBOXYLIC ACIDS TO 2,5-FURANDICARBOXYLIC ACID [patent_app_type] => utility [patent_app_number] => 17/377851 [patent_app_country] => US [patent_app_date] => 2021-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377851 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/377851
Method and integrated process for the carboxylation of furan derived carboxylic acids to 2,5-furandicarboxylic acid Jul 15, 2021 Issued
Array ( [id] => 18420064 [patent_doc_number] => 20230174525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => POLYMORPHS OF A HYDROCHLORIDE SALT OF PN6047 [patent_app_type] => utility [patent_app_number] => 18/015828 [patent_app_country] => US [patent_app_date] => 2021-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7928 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015828 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015828
POLYMORPHS OF A HYDROCHLORIDE SALT OF PN6047 Jul 11, 2021 Pending
Array ( [id] => 18535973 [patent_doc_number] => 20230241060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => GLUCOCORTICOID-SPARING AGENT [patent_app_type] => utility [patent_app_number] => 18/004806 [patent_app_country] => US [patent_app_date] => 2021-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17462 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004806 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/004806
GLUCOCORTICOID-SPARING AGENT Jul 7, 2021 Pending
Array ( [id] => 18753846 [patent_doc_number] => 20230357148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => INDOLE DERIVATIVE AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/013688 [patent_app_country] => US [patent_app_date] => 2021-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9796 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013688 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/013688
Indole derivative and application thereof Jul 1, 2021 Issued
Array ( [id] => 17185194 [patent_doc_number] => 20210332079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => SQUALAMINE SOLID FORMS AND METHODS OF MAKING THE SAME [patent_app_type] => utility [patent_app_number] => 17/365208 [patent_app_country] => US [patent_app_date] => 2021-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21761 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365208 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/365208
SQUALAMINE SOLID FORMS AND METHODS OF MAKING THE SAME Jun 30, 2021 Abandoned
Array ( [id] => 18496096 [patent_doc_number] => 20230218639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING NEUROLOGICAL CONDITIONS, NEURODEGENERATIVE DISEASES, AND ADDICTION [patent_app_type] => utility [patent_app_number] => 18/008560 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16473 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008560 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/008560
USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING NEUROLOGICAL CONDITIONS, NEURODEGENERATIVE DISEASES, AND ADDICTION Jun 24, 2021 Pending
Array ( [id] => 18647779 [patent_doc_number] => 20230293551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AUTOIMMUNE CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/008582 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14883 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008582 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/008582
USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AUTOIMMUNE CONDITIONS Jun 24, 2021 Abandoned
Array ( [id] => 18626619 [patent_doc_number] => 20230285416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AT LEAST ONE OF INSULIN RESISTANCE, DIABETES, AND PREDIABETES [patent_app_type] => utility [patent_app_number] => 18/008588 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20551 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008588 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/008588
USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AT LEAST ONE OF INSULIN RESISTANCE, DIABETES, AND PREDIABETES Jun 24, 2021 Pending
Array ( [id] => 17609762 [patent_doc_number] => 20220152041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => CALMODULIN INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISORDERS AND RIBOSOMAPATHIES [patent_app_type] => utility [patent_app_number] => 17/353717 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353717 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/353717
Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies Jun 20, 2021 Issued
Array ( [id] => 18665216 [patent_doc_number] => 11772082 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-10-03 [patent_title] => Catalyst supports--composition and process of manufacture [patent_app_type] => utility [patent_app_number] => 17/347620 [patent_app_country] => US [patent_app_date] => 2021-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9589 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347620 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/347620
Catalyst supports--composition and process of manufacture Jun 14, 2021 Issued
Array ( [id] => 17428279 [patent_doc_number] => 20220055987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => COMPOSITIONS OF TROFINETIDE [patent_app_type] => utility [patent_app_number] => 17/347135 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12381 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347135 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/347135
Compositions of trofinetide Jun 13, 2021 Issued
Array ( [id] => 18497296 [patent_doc_number] => 20230219910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => CRYSTALLINE FORMS OF {2-[3-CYCLOHEXYL-3-(TRANS-4-PROPOXY-CYCLOHEXYL)-UREIDO]-THIAZOL-5-YLSULFANYL}-ACETIC ACID AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/000908 [patent_app_country] => US [patent_app_date] => 2021-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -104 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000908 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000908
CRYSTALLINE FORMS OF {2-[3-CYCLOHEXYL-3-(TRANS-4-PROPOXY-CYCLOHEXYL)-UREIDO]-THIAZOL-5-YLSULFANYL}-ACETIC ACID AND USES THEREOF Jun 6, 2021 Pending
Array ( [id] => 18610798 [patent_doc_number] => 20230277528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => COMPOSITIONS AND METHODS FOR HAIR FOLLICLE REGENERATION [patent_app_type] => utility [patent_app_number] => 18/009050 [patent_app_country] => US [patent_app_date] => 2021-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13102 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009050 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/009050
COMPOSITIONS AND METHODS FOR HAIR FOLLICLE REGENERATION Jun 2, 2021 Pending
Array ( [id] => 17228543 [patent_doc_number] => 20210355099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => HIGHLY EFFICIENT SYNTHESIS OF Z-MACROCYCLES USING STEREORETENTIVE, RUTHENIUM-BASED METATHESIS CATALYSTS [patent_app_type] => utility [patent_app_number] => 17/336756 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10877 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336756 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/336756
Highly efficient synthesis of Z-macrocycles using stereoretentive, ruthenium-based metathesis catalysts Jun 1, 2021 Issued
Array ( [id] => 17297773 [patent_doc_number] => 20210393612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => POLYMORPHIC COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/334094 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41287 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334094 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/334094
Polymorphic compounds and uses thereof May 27, 2021 Issued
Menu